SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-022869
Filing Date
2018-04-27
Accepted
2018-04-27 08:30:47
Documents
3
Period of Report
2018-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv492178_8k.htm 8-K 22625
2 EXHIBIT 99.1 tv492178_ex99-1.htm EX-99.1 13260
3 GRAPHIC image_001.jpg GRAPHIC 2260
  Complete submission text file 0001144204-18-022869.txt   40458
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 18781121
SIC: 2834 Pharmaceutical Preparations